RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00032260.xml
PDF herunterladen
Digestive Disease Interventions 2022; 06(01): 013-018
DOI: 10.1055/s-0041-1740266
DOI: 10.1055/s-0041-1740266
Review Article
Liquid Embolics: A Guide to Currently Available and Pipeline Products
Funding This study was not supported by grant funding.
Abstract
Over the last decade, several publications have reported the safety and efficacy of liquid embolics in a wide range of clinical indications. The expansion of clinical scenarios in which liquid embolics are utilized has been in part driven by some of the advantages these materials hold over other embolic agents. For instance, liquid embolics do not rely on the patient's ability to form clot and can be delivered more distally then coils at times. While several liquid embolics are commercially available, and in some cases have been for decades, there are limitations to these materials as well. The potential benefits of liquid embolics combined with the limitations of available materials have led to the ongoing development of several new agents. This review aims to familiarize the reader with both available liquid embolics and those that are relatively new or in development.
Publikationsverlauf
Eingereicht: 27. Mai 2021
Angenommen: 18. Oktober 2021
Artikel online veröffentlicht:
30. November 2021
© 2021. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Lubarsky M, Ray CE, Funaki B. Embolization agents-which one should be used when? Part 1: large-vessel embolization. Semin Intervent Radiol 2009; 26 (04) 352-357
- 2 Loffroy R, Guiu B, Cercueil JP, Krausé D. Endovascular therapeutic embolisation: an overview of occluding agents and their effects on embolised tissues. Curr Vasc Pharmacol 2009; 7 (02) 250-263
- 3 Pollak JS, White Jr RI. The use of cyanoacrylate adhesives in peripheral embolization. J Vasc Interv Radiol 2001; 12 (08) 907-913
- 4 Vinters HV, Galil KA, Lundie MJ, Kaufmann JC. The histotoxicity of cyanoacrylates: a selective review. Neuroradiology 1985; 27 (04) 279-291
- 5 Stoesslein F, Ditscherlein G, Romaniuk PA. Experimental studies on new liquid embolization mixtures (histoacryl-lipiodol, histoacryl-panthopaque). Cardiovasc Intervent Radiol 1982; 5 (05) 264-267
- 6 Tamatani S, Koike T, Ito Y, Tanaka R. Embolization of arteriovenous malformation with diluted mixture of NBCA. Interv Neuroradiol 2000; 6 (Suppl. 01) 187-190
- 7 Luz JHM, Luz PM, Bilhim T. et al. Portal vein embolization with n-butyl-cyanoacrylate through an ipsilateral approach before major hepatectomy: single center analysis of 50 consecutive patients. Cancer Imaging 2017; 17 (01) 25
- 8 Seron A, Moine L, Laurent A. et al. An embolic gelling solution based on acrylic copolymers in ethanol for the treatment of arteriovenous malformations. Biomaterials 2009; 30 (20) 3436-3443
- 9 Chaloupka JC, Huddle DC, Alderman J, Fink S, Hammond R, Vinters HV. A reexamination of the angiotoxicity of superselective injection of DMSO in the swine rete embolization model. AJNR Am J Neuroradiol 1999; 20 (03) 401-410
- 10 Flores BC, See AP, Weiner GM, Jankowitz BT, Ducruet AF, Albuquerque FC. Use of the Apollo detachable-tip microcatheter for endovascular embolization of arteriovenous malformations and arteriovenous fistulas. J Neurosurg 2018; 130 (03) 963-971
- 11 Bharadwaz A, Madhab G. Liquid embolization with onyx in a technically challenging case of acute upper GI bleeding. Indian J Surg 2013; 75 (Suppl. 01) 495-496
- 12 Urbano J, Manuel Cabrera J, Franco A, Alonso-Burgos A. Selective arterial embolization with ethylene-vinyl alcohol copolymer for control of massive lower gastrointestinal bleeding: feasibility and initial experience. J Vasc Interv Radiol 2014; 25 (06) 839-846
- 13 Né R, Chevallier O, Falvo N. et al. Embolization with ethylene vinyl alcohol copolymer (Onyx®) for peripheral hemostatic and non-hemostatic applications: a feasibility and safety study. Quant Imaging Med Surg 2018; 8 (03) 280-290
- 14 Çil BE, Çay F, Peynircioğlu B, Altan E, Kav T. Transhepatic antegrade embolization of the esophageal and gastric varices with Onyx®. Turk J Gastroenterol 2016; 27 (06) 557-559
- 15 Craig P, Young S, Golzarian J. Current trends in the treatment of hepatocellular carcinoma with transarterial embolization: variability in technical aspects. Cardiovasc Intervent Radiol 2019; 42 (09) 1322-1328
- 16 Young S, Craig P, Golzarian J. Current trends in the treatment of hepatocellular carcinoma with transarterial embolization: a cross-sectional survey of techniques. Eur Radiol 2019; 29 (06) 3287-3295
- 17 de Baère T, Denys A, Briquet R, Chevallier P, Dufaux J, Roche A. Modification of arterial and portal hemodynamics after injection of iodized oils and different emulsions of iodized oils in the hepatic artery: an experimental study. J Vasc Interv Radiol 1998; 9 (02) 305-310
- 18 Okuno Y, Korchi AM, Shinjo T, Kato S. Transcatheter arterial embolization as a treatment for medial knee pain in patients with mild to moderate osteoarthritis. Cardiovasc Intervent Radiol 2015; 38 (02) 336-343
- 19 Woodhams R, Nishimaki H, Ogasawara G. et al. Imipenem/cilastatin sodium (IPM/CS) as an embolic agent for transcatheter arterial embolisation: a preliminary clinical study of gastrointestinal bleeding from neoplasms. Springerplus 2013; 2: 344
- 20 Aihara T. A basic study of super-selective transcatheter arterial chemotherapy and chemoembolization (1)-establishment of an animal model for superselective transcatheter arterial chemotherapy and preparation for appropriate suspension of microembolization. Kawasaki Igakkaishi 1999; 25: 47-54
- 21 Okuno Y, Matsumura N, Oguro S. Transcatheter arterial embolization using imipenem/cilastatin sodium for tendinopathy and enthesopathy refractory to nonsurgical management. J Vasc Interv Radiol 2013; 24 (06) 787-792
- 22 Vaidya S, Tozer KR, Chen J. An overview of embolic agents. Semin Intervent Radiol 2008; 25 (03) 204-215
- 23 Yu SCH, Hui EP, Wong J. et al. Transarterial ethanol ablation of hepatocellular carcinoma with lipiodol ethanol mixture: phase II study. J Vasc Interv Radiol 2008; 19 (01) 95-103
- 24 Fan XD, Su LX, Zheng JW, Zheng LZ, Zhang ZY. Ethanol embolization of arteriovenous malformations of the mandible. AJNR Am J Neuroradiol 2009; 30 (06) 1178-1183
- 25 Baek HJ, Hong JP, Choi JW, Suh DC. Direct percutaneous alcohol sclerotherapy for venous malformations of head and neck region without fluoroscopic guidance: technical consideration and outcome. Neurointervention 2011; 6 (02) 84-88
- 26 Sakuhara Y, Abo D, Hasegawa Y. et al. Preoperative percutaneous transhepatic portal vein embolization with ethanol injection. AJR Am J Roentgenol 2012; 198 (04) 914-922
- 27 Shin BS, Do YS, Lee BB. et al. Multistage ethanol sclerotherapy of soft-tissue arteriovenous malformations: effect on pulmonary arterial pressure. Radiology 2005; 235 (03) 1072-1077
- 28 Prasetyono TOH, Kreshanti P. Efficacy of intra-lesional alcohol injection as alternative and/or complementary treatment of vascular malformations: a systematic review. J Plast Reconstr Aesthet Surg 2010; 63 (07) 1071-1079
- 29 Lord J, Britton H, Spain SG, Lewis AL. Advancements in the development on new liquid embolic agents for use in therapeutic embolisation. J Mater Chem B Mater Biol Med 2020; 8 (36) 8207-8218
- 30 Ganguli S, Lareau R, Jarrett T, Soulen MC. A water-based liquid embolic: evaluation of safety and efficacy in a rabbit kidney model. J Vasc Interv Radiol 2021; 32 (06) 813-818
- 31 Ganguli S, Weintraub T, Dibartholomeo R, Lareau H, Claesson R, Bean A. A novel aqueous liquid hydrogel embolic for peripheral vascular applications. J Vasc Interv Radiol 2019; 3 (30) s170
- 32 Brennecka CR, Preul MC, Bichard WD, Vernon BL. In vivo experimental aneurysm embolization in a swine model with a liquid-to-solid gelling polymer system: initial biocompatibility and delivery strategy analysis. World Neurosurg 2012; 78 (05) 469-480
- 33 Brennecka CR, Preul MC, Becker TA, Vernon BL. In vivo embolization of lateral wall aneurysms in canines using the liquid-to-solid gelling PPODA-QT polymer system: 6-month pilot study. J Neurosurg 2013; 119 (01) 228-238
- 34 Lozupone E, Bracco S, Trombatore P. et al. Endovascular treatment of cerebral dural arteriovenous fistulas with SQUID 12. Interv Neuroradiol 2020; 26 (05) 651-657
- 35 Pedicelli A, Lozupone E, Valente I. et al. Pre-operative direct puncture embolization of head and neck hypervascular tumors using SQUID 12. Interv Neuroradiol 2020; 26 (03) 346-353
- 36 Venturini M, Lanza C, Marra P. et al. Transcatheter embolization with Squid, combined with other embolic agents or alone, in different abdominal diseases: a single-center experience in 30 patients. CVIR Endovasc 2019; 2 (01) 8
- 37 Venturini M, Augello L, Lanza C. et al. Emergency tips recanalisation and gastroesophageal varices embolisation with an ethylene vinyl alcohol copolymer agent (Squid) and detachable coils. Eur Radiol Exp 2020; 4 (01) 67
- 38 Schmitt N, Floca RO, Paech D. et al. Imaging artifacts of liquid embolic agents on conventional CT in an experimental in vitro model. AJNR Am J Neuroradiol 2021; 42 (01) 126-131
- 39 Vollherbst DF, Otto R, Do T. et al. Imaging artifacts of Onyx and PHIL on conventional CT, cone-beam CT and MRI in an animal model. Interv Neuroradiol 2018; 24 (06) 693-701
- 40 Sirakov A, Minkin K, Sirakov S. Intermixed dimethyl-sulfoxide-based nonadhesive liquid embolic agents delivered serially via the same microcatheter for cerebral AVM treatment. AJNR Am J Neuroradiol 2020; 41 (04) 681-686
- 41 Sirakov SS, Sirakov A, Minkin K. et al. Initial experience with precipitating hydrophobic injectable liquid in cerebral arteriovenous malformations. Interv Neuroradiol 2019; 25 (01) 58-65
- 42 Lucatelli P, Corona M, Teodoli L. et al. Use of PHIL embolic agent for bleeding in non-neurological interventions. J Clin Med 2021; 10 (04) 701
- 43 Giurazza F, Corvino F, Silvestre M. et al. Embolization of peripheral arteriovenous malformations and fistulas with precipitating hydrophobic injectable liquid (PHIL®). Radiol Med (Torino) 2021; 126 (03) 474-483
- 44 Vollherbst DF, Sommer CM, Ulfert C, Pfaff J, Bendszus M, Möhlenbruch MA. Liquid embolic agents for endovascular embolization: evaluation of an established (Onyx) and a novel (PHIL) embolic agent in an in vitro AVM model. AJNR Am J Neuroradiol 2017; 38 (07) 1377-1382
- 45 Koçer N, Hanımoğlu H, Batur Ş. et al. Preliminary experience with precipitating hydrophobic injectable liquid in brain arteriovenous malformations. Diagn Interv Radiol 2016; 22 (02) 184-189
- 46 Kulcsár Z, Karol A, Kronen PW. et al. A novel, non-adhesive, precipitating liquid embolic implant with intrinsic radiopacity: feasibility and safety animal study. Eur Radiol 2017; 27 (03) 1248-1256
- 47 Agusti G, Jordan O, Andersen G, Doelker E, Chevalier Y. Radiopaque iodinated ethers of poly(vinyl iodobenzyl ether)s: synthesis and evaluation for endovascular embolization. J Appl Polym Sci 2015; 132: 41791
- 48 Tamura G, Kato N, Yamazaki T. et al. Endovascular embolization of brain arteriovenous malformations with Eudragit-E. Neurol Med Chir (Tokyo) 2015; 55 (03) 253-260
- 49 Arakawa H, Murayama Y, Davis CR. et al. Endovascular embolization of the swine rete mirabile with Eudragit-E 100 polymer. AJNR Am J Neuroradiol 2007; 28 (06) 1191-1196
- 50 Yamashita K, Taki W, Iwata H, Kikuchi H. A cationic polymer, Eudragit-E, as a new liquid embolic material for arteriovenous malformations. Neuroradiology 1996; 38 (Suppl. 01) S151-S156
- 51 Stewart RJ, Wang CS, Song IT, Jones JP. The role of coacervation and phase transitions in the sandcastle worm adhesive system. Adv Colloid Interface Sci 2017; 239: 88-96
- 52 Karz JJ. GPX by Fluidx Medical Technology: a new proprietary in situ setting embolic agent that combines the benefits of coils, gel beas, and liquid embolics. J Vasc Interv Radiol 2018; 29 (04) S174
- 53 Jones J, Karz J, Blossom D, Johnson M. Transcatheter embolization in swine models with GPX, a novel water-borne polymer embolic. J Vasc Interv Radiol 2019; 30 (03) S200-S201
- 54 Jones J, O'Hara R, Jonson M, Olsen A. A chronic comparison of clinically used embolic agents with GPX in domestic swine. J Vasc Interv Radiol 2020; 31 (03) S170
- 55 Baba Y, Higashi M, Awai K. Minimally invasive therapy and allied technologies. Minim Invasive Ther Allied Technol 2018; 27 (01) 17-21
- 56 Hayashi S, Baba Y, Senokuchi T. et al. An experimental study of the hemostasis agent PuraMatrix use for embolic agent. Jpn J Intervent Radiol. 2017; 32: S195
- 57 Uraoka T, Ochiai Y, Fujimoto A. et al. A novel fully synthetic and self-assembled peptide solution for endoscopic submucosal dissection-induced ulcer in the stomach. Gastrointest Endosc 2016; 83 (06) 1259-1264
- 58 Barnett BP, Gailloud P. Assessment of EmboGel – a selectively dissolvable radiopaque hydrogel for embolic applications. J Vasc Interv Radiol 2011; 22 (02) 203-211
- 59 Barnett BP, Hughes AH, Lin S, Arepally A, Gailloud PH. In vitro assessment of EmboGel and UltraGel radiopaque hydrogels for the endovascular treatment of aneurysms. J Vasc Interv Radiol 2009; 20 (04) 507-512